Life Sciences
Opko Health Sees Health of Its Charts Improve
The parent of BioReference Labs is sending some bullish signals amid a nice recent run higher in its shares.
Covid-19 Complications, Grocery Store-y, More on Moderna: Market Recon
Plus, a closer look at Thursday's late-day rally and at actions impacting the nation's big banks.
9 Bargain Stocks to Watch in Asia's Worst-Performing Market
Indonesian stocks have done poorly this year, but these nine stocks could rate attention if investors rediscover the market.
Edwards Lifesciences Appears Healthy, but Too Early for Full Prognosis
EW's charts are constructive, but prices need to push up into resistance to signal that a breakout is possible.
Moderna's Rally Is Not Over: Our Latest Trading Strategy
Thursday's rally was sparked by news that Moderna's Covid-19 vaccine candidate is moving to Phase II testing.
Alexandria Real Estate Equities Offers Yield and a Modest Upside Target
The charts and indicators of ARE are heading in the right direction but not with convincing volume.
Agilent Technologies Could Regain Its Former Peak
CEO McMullen said it's not a matter of if they'll have a vaccine, but when.
GlaxoSmithKline Charts Prescribe Positive Outlook as It Chases Covid-19 Vaccine
The drugmaker that is partnering with Sanofi to develop a vaccine has seen its shares push higher after declining to a low in late March.
This Dividend Aristocrat Should Keep Your Portfolio Healthy
With a strong history in an important industry, Becton Dickinson looks set to provide and increase its dividend through this crisis and beyond.
Go Long Veeva Systems on Strength as the Rally Could Extend Further
The technical signals for the technology provider to the life science industry show its shares have upside potential.